[Federal Register: March 29, 2004 (Volume 69, Number 60)]
[Page 16275]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



Food and Drug Administration

Nutrition Subcommittee of the Food Advisory Committee; Notice of 

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Nutrition Subcommittee of the Food Advisory 
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on April 27, 2004, from 
12:30 p.m. to 6 p.m., and April 28, 2004, from 8 a.m. to 4 p.m.
    Location: Loew's L'Enfant Plaza Hotel, 480 L'Enfant Plaza, 
Washington, DC.
    Contact Person: Jeanne Latham, Center for Food Safety and Applied 
Nutrition (HFS-800), Food and Drug Administration, 5100 Paint Branch 
Pkwy., College Park, MD 20740, 301-436-1756, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 3014510564. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: The subcommittee will discuss the scientific issues and 
principles involved in using ``total fat'' as a disqualifying level for 
foods that receive a health claim for coronary heart disease; and to 
discuss evidence supporting a possible daily value (DV) for trans fatty 
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the subcommittee. 
Written submissions may be made to the contact person by April 13, 
2004. Oral presentations from the public will be scheduled between 
approximately 5 p.m. and 6 p.m. on April 27, 2004. Time allotted for 
each presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before April 22, 2004, 
and submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Jeanne Latham at 
least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: March 19, 2004.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 04-6921 Filed 3-26-04; 8:45 am]